PDS Biotechnology Corp (NASDAQ:PDSB) is held by 39 institutional investors per 13F filings through March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,631,089 | 1,631,089 | 0.00% | $986,809.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 660,228 | 139,830 | 26.87% | $399,489.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 554,048 | 31,837 | 6.10% | $335,199.00 |
| VANGUARD FIDUCIARY TRUST CO | 31 Mar, 2026 | 307,311 | 307,311 | 0.00% | $185,923.00 |
| BLAIR WILLIAM & CO/IL | 31 Mar, 2026 | 300,000 | 50,000 | 20.00% | $181,500.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 220,800 | 44,100 | 24.96% | $133,584.00 |
| INSPIRION WEALTH ADVISORS, LLC | 31 Mar, 2026 | 181,995 | 1,500 | 0.83% | $110,107.00 |
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 173,605 | -2,660,901 | -93.88% | $105,031.00 |
| State Street Corp | 31 Mar, 2026 | 133,333 | 0 | 0.00% | $80,666.00 |
| Wells Fargo & Company/Mn | 31 Mar, 2026 | 110,500 | 105,171 | 1,973.56% | $66,853.00 |
| Northern Trust Corp | 31 Mar, 2026 | 108,893 | -34,980 | -24.31% | $65,880.00 |
| COMMONWEALTH EQUITY SERVICES, LLC | 31 Mar, 2026 | 90,797 | -106,000 | -53.86% | $54,930.00 |
| Iron Gate Global Advisors LLC | 31 Mar, 2026 | 75,022 | 6 | 0.01% | $45,388.00 |
| Bank of New York Mellon Corp | 31 Mar, 2026 | 69,311 | 0 | 0.00% | $41,934.00 |
| NINE MASTS CAPITAL Ltd | 31 Mar, 2026 | 67,507 | 67,507 | 0.00% | $40,842.00 |
| Tempus Wealth Planning, LLC | 31 Mar, 2026 | 61,800 | 0 | 0.00% | $37,389.00 |
| UBS Group AG | 31 Mar, 2026 | 56,004 | -195,701 | -77.75% | $33,882.00 |
| XTX Topco Ltd | 31 Mar, 2026 | 36,211 | 1,993 | 5.82% | $21,908.00 |
| TWO SIGMA SECURITIES, LLC | 31 Mar, 2026 | 31,481 | 31,481 | 0.00% | $19,046.00 |
| ACT CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 30,000 | 0 | 0.00% | $18,150.00 |